Bell Rose Capital Inc

Bell Rose Capital Inc. develops anti‑viral drugs for Hep C and HIV/AIDS while launching AI‑powered logistics platform LENIE, yet its stock remains highly volatile and low‑liquidity, prompting investor caution.

Bell Rose Capital Inc. is a U.S.-based company specializing in pharmaceuticals for viral infections, with a focus on research and development of anti-viral therapies.